miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
about
Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesisRoles of the canonical myomiRs miR-1, -133 and -206 in cell development and diseaseFilopodia and adhesion in cancer cell motilityEpidemiological studies of esophageal cancer in the era of genome-wide association studiesmiRNA and mammalian male germ cellsThe crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancerThe somatic genomic landscape of chromophobe renal cell carcinomaHEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators?Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMTThe clinicopathological significance of miR-133a in colorectal cancer.Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death.Inferring the perturbed microRNA regulatory networks from gene expression data using a network propagation based method.MicroRNA-203 inhibits cell proliferation by repressing ΔNp63 expression in human esophageal squamous cell carcinoma.A Systematic Evaluation of Feature Selection and Classification Algorithms Using Simulated and Real miRNA Sequencing Data.Identification of colorectal cancer-restricted microRNAs and their target genes based on high-throughput sequencing dataAccurate quantification of microRNA via single strand displacement reaction on DNA origami motif.MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells.MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1.MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinomaA computationally constructed ceRNA interaction network based on a comparison of the SHEE and SHEEC cell lines.A potential role for intragenic miRNAs on their hosts' interactome.MicroRNA-375 suppresses esophageal cancer cell growth and invasion by repressing metadherin expressionLong noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.miR-145 downregulates the expression of cyclin-dependent kinase 6 in human cervical carcinoma cells.Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer.A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cellsmiR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancerTumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinomaThe cluster of miR-143 and miR-145 affects the risk for esophageal squamous cell carcinoma through co-regulating fascin homolog 1Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population.MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis.Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers.Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth.
P2860
Q26783563-6EDD6285-1298-43B6-BB2D-A6ED501FD74BQ26795757-11712185-30EB-4E39-8C66-C37730F07EF8Q26823315-1CC7D851-4494-4C55-B4C7-ABD11B2A29B9Q26852690-72ED4110-FA41-43D2-8395-291D74A407B7Q26992374-FA78C067-1EA5-4979-B822-62BA5F0ED814Q28076568-B0951142-E351-46B4-B370-4CF1009AAF47Q28246658-8185B275-376B-40EB-BF60-E04D14959314Q28284329-F8E06F2E-A587-4D11-B787-51CCBDCDE317Q28389159-EB2AE566-FF30-4C35-91BC-8116FD48BD6CQ28744173-F7DDE390-05F3-420B-ABFB-7FB07EBFF5F7Q30009338-3CCB7F3B-4AE4-4B1A-A9F5-F85EB7D2CAB8Q30620884-B1536318-E640-4FB0-B51C-15768C75B9A3Q30839150-0C524F82-0F7F-4AA4-A718-E76A761FE404Q30998761-2927DBA8-98B0-4F62-9B92-25C89009F5D1Q31012249-340FD040-1583-4676-9EDD-E7323DFB6993Q31074578-A613C712-A58F-40C0-A842-1E7F214CAAB8Q31130590-0F972ECD-4307-4BF2-A299-117B0B866F46Q31148368-639BBD6D-50D1-4317-B077-9DCA3460B1F4Q33555201-E7D4D69C-CB6C-4816-97D4-7425E07DB0AFQ33590325-10B52517-3B4F-4D61-BE57-140121F92734Q33634762-208805BC-F404-4A9C-AAF2-5FC609BE26D0Q33710067-8BC5FAA6-4059-4058-A8AE-7B715D0AB155Q33751069-9B65B5FE-B08E-4839-B874-C3F7E6FE7F4FQ33779396-E205EC1E-1B65-4B52-81C3-BD74035E1B1BQ33837378-88E40F2A-E319-4AC2-BAA0-6E27044B3DDCQ33862088-6C20370F-E912-458B-A428-09753BA116C3Q33895931-DC524AAD-FA7B-40B1-867E-2E37B61909AAQ33898799-A6C2A8C9-DFF3-4CF2-B788-EC1F6F2811E2Q33973612-920F61AE-1320-4717-921A-D9EA08A4E4ECQ34130721-2E367236-C1F1-4E16-A258-1E06819BA2A1Q34146970-75BB4278-28E3-4F5E-B593-B22FD59955F8Q34163386-BBE064A8-489E-4339-B178-61319411FA0EQ34208496-7CBF5EC5-DB59-49D2-B4DD-EC91DBE6927DQ34212106-9769CCB9-6A57-4424-B2FC-A0146021C7AEQ34221705-8B4E1F14-2551-48AD-AA94-DC9751DDFC9CQ34231578-810B0522-D264-4B2A-8622-E7D62F6FF318Q34245074-9294152C-8587-429F-8F56-11E324D92EB4Q34251059-03013323-19FB-4870-9011-1232848BC2E9Q34252329-F9282FB3-DEE4-43D4-A76D-FD28AD3D06BAQ34275817-3089F813-1D3A-404D-A1AD-E690010739F8
P2860
miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
miR-145, miR-133a and miR-133b ...... ageal squamous cell carcinoma.
@ast
miR-145, miR-133a and miR-133b ...... ageal squamous cell carcinoma.
@en
miR-145, miR-133a and miR-133b ...... ageal squamous cell carcinoma.
@nl
type
label
miR-145, miR-133a and miR-133b ...... ageal squamous cell carcinoma.
@ast
miR-145, miR-133a and miR-133b ...... ageal squamous cell carcinoma.
@en
miR-145, miR-133a and miR-133b ...... ageal squamous cell carcinoma.
@nl
prefLabel
miR-145, miR-133a and miR-133b ...... ageal squamous cell carcinoma.
@ast
miR-145, miR-133a and miR-133b ...... ageal squamous cell carcinoma.
@en
miR-145, miR-133a and miR-133b ...... ageal squamous cell carcinoma.
@nl
P2093
P356
P1476
miR-145, miR-133a and miR-133b ...... ageal squamous cell carcinoma.
@en
P2093
Hideki Enokida
Hisahiro Matsubara
Isamu Hoshino
Lisa Fujimura
Masayuki Kano
Masayuki Nakagawa
Naohiko Seki
Naoko Kikkawa
Takeshi Chiyomaru
Yasunori Akutsu
P304
P356
10.1002/IJC.25284
P577
2010-12-01T00:00:00Z